These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12814661)

  • 1. The GBeta5 subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effects.
    Sánchez-Blázquez P; Rodríguez-Díaz M; López-Fando A; Rodríguez-Muñoz M; Garzón J
    Neuropharmacology; 2003 Jul; 45(1):82-95. PubMed ID: 12814661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of neural RGS-R7 and Gbeta5 Proteins in Response to Acute and Chronic Morphine.
    López-Fando A; Rodríguez-Muñoz M; Sánchez-Blázquez P; Garzón J
    Neuropsychopharmacology; 2005 Jan; 30(1):99-110. PubMed ID: 15199376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The R7 subfamily of RGS proteins assists tachyphylaxis and acute tolerance at mu-opioid receptors.
    Garzón J; López-Fando A; Sánchez-Blázquez P
    Neuropsychopharmacology; 2003 Nov; 28(11):1983-90. PubMed ID: 12902995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGS9 proteins facilitate acute tolerance to mu-opioid effects.
    Garzón J; Rodríguez-Díaz M; López-Fando A; Sánchez-Blázquez P
    Eur J Neurosci; 2001 Feb; 13(4):801-11. PubMed ID: 11207815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGSZ1 and GAIP regulate mu- but not delta-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance.
    Garzón J; Rodríguez-Muñoz M; López-Fando A; García-España A; Sánchez-Blázquez P
    Neuropsychopharmacology; 2004 Jun; 29(6):1091-104. PubMed ID: 14997173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins.
    Garzón J; Rodríguez-Muñoz M; López-Fando A; Sánchez-Blázquez P
    Neuropsychopharmacology; 2005 Sep; 30(9):1632-48. PubMed ID: 15827571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
    Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS.
    Garzón J; Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P
    Psychopharmacology (Berl); 2005 Jun; 180(1):1-11. PubMed ID: 15830230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists.
    Sánchez-Blázquez P; García-España A; Garzón J
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization.
    Garzón J; Rodríguez-Muñoz M; López-Fando A; Sánchez-Blázquez P
    J Biol Chem; 2005 Mar; 280(10):8951-60. PubMed ID: 15632124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter.
    Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
    Neuropharmacology; 2005 May; 48(6):853-68. PubMed ID: 15829256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H; Wang X; Wang J; Rothman RB
    Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors.
    Sánchez-Blázquez P; García-Espãna A; Garzón J
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1423-31. PubMed ID: 9067332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Gz and Gi2 transducer proteins in the affinity of opioid agonists to mu receptors.
    Garzón J; Castro M; Sánchez-Blázquez P
    Eur J Neurosci; 1998 Aug; 10(8):2557-64. PubMed ID: 9767386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
    Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
    Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and G(x/z) transducer proteins in mouse periaqueductal gray matter.
    Garzón J; García-España A; Sánchez-Blázquez P
    J Pharmacol Exp Ther; 1997 Apr; 281(1):549-57. PubMed ID: 9103543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Galphaz subunits.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Montero C; Garzón J
    Neuropharmacology; 2005 Jan; 48(1):134-50. PubMed ID: 15617734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain.
    Garzón J; Rodríguez-Díaz M; López-Fando A; García-España A; Sánchez-Blázquez P
    Neuropharmacology; 2002 May; 42(6):813-28. PubMed ID: 12015208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.